LifeMine Therapeutics and GSK enter drug discovery and development alliance
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease
Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes
Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now
Data published in the prestigious journal ACS Central Science of the American Chemical Society
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform
Successful proposals will secure fully funded postdoctoral research positions
Subscribe To Our Newsletter & Stay Updated